HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hendrik Vilstrup Selected Research

satavaptan

7/2022Spontaneous bacterial peritonitis has no effect on the long-term prognosis of cirrhosis patients with ascites.
1/2022Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
11/2019Improvement of hyponatremia in cirrhosis is associated with improved complex information processing.
5/2019Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascites.
1/2019Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites.
1/2019Quality of life measures predict mortality in patients with cirrhosis and severe ascites.
10/2018Un-precipitated acute kidney injury is uncommon among stable patients with cirrhosis and ascites.
10/2016Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
7/2016Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study.
1/2016Nonselective β-blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hendrik Vilstrup Research Topics

Disease

75Fibrosis (Cirrhosis)
07/2022 - 03/2002
41Hepatic Encephalopathy
01/2022 - 01/2003
29Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 05/2002
25Ascites
07/2022 - 12/2003
21Liver Diseases (Liver Disease)
01/2022 - 06/2009
18Hemorrhage
01/2019 - 05/2002
16Non-alcoholic Fatty Liver Disease
01/2022 - 03/2003
14Inflammation (Inflammations)
01/2022 - 04/2010
12Portal Hypertension
11/2018 - 01/2003
11Infections
05/2022 - 01/2003
11Alcoholic Hepatitis
03/2021 - 09/2011
11Hyperammonemia
01/2021 - 06/2007
10Insulin Resistance
01/2022 - 03/2003
9Liver Failure
01/2021 - 01/2003
9Fatty Liver
11/2019 - 03/2003
8Alcoholic Fatty Liver
11/2019 - 04/2014
8End Stage Liver Disease
01/2019 - 01/2010
7Neoplasms (Cancer)
01/2021 - 01/2002
7Acute-Phase Reaction
01/2017 - 02/2005
5Necrosis
01/2021 - 01/2011
5Varicose Veins (Varicose Vein)
10/2018 - 03/2003
4Brain Diseases (Brain Disorder)
01/2021 - 01/2003
4Glucose Intolerance
10/2019 - 06/2005
4Peritonitis
01/2019 - 12/2003
4Alcoholic Liver Diseases (Alcoholic Liver Disease)
10/2017 - 08/2005
3Hepatolenticular Degeneration (Wilson's Disease)
01/2022 - 10/2021
3Obesity
01/2022 - 10/2019
3Disease Progression
03/2021 - 03/2017
3Chronic Hepatitis C
01/2020 - 11/2006
3Chronic Disease (Chronic Diseases)
01/2020 - 01/2019
3Hyponatremia
11/2019 - 10/2018
3Hepatocellular Carcinoma (Hepatoma)
03/2019 - 09/2014
3Hepatorenal Syndrome
05/2016 - 01/2016
3Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
02/2011 - 05/2010
2Cognitive Dysfunction
03/2022 - 01/2019
2Hyperglycemia
10/2019 - 06/2005

Drug/Important Bio-Agent (IBA)

20AmmoniaIBA
01/2022 - 01/2006
19Urea (Carbamide)FDA LinkGeneric
05/2022 - 02/2005
13satavaptanIBA
07/2022 - 01/2012
13SodiumIBA
01/2022 - 08/2005
13Insulin (Novolin)FDA Link
01/2022 - 03/2002
13Glucose (Dextrose)FDA LinkGeneric
11/2019 - 06/2005
13Lactulose (Duphalac)FDA LinkGeneric
10/2019 - 06/2013
12EnzymesIBA
01/2021 - 02/2005
11Proteins (Proteins, Gene)FDA Link
03/2022 - 12/2003
11Branched-Chain Amino AcidsIBA
04/2018 - 03/2009
10Galactose (Galactopyranose)FDA LinkGeneric
01/2022 - 02/2005
10NitrogenIBA
01/2020 - 02/2005
8Amino AcidsFDA Link
01/2021 - 03/2009
8Messenger RNA (mRNA)IBA
11/2019 - 02/2005
7DiureticsIBA
01/2022 - 01/2007
7Glutamine (L-Glutamine)FDA Link
01/2021 - 01/2006
7LipopolysaccharidesIBA
01/2017 - 02/2005
6Insulin-Like Growth Factor I (IGF-1)IBA
08/2015 - 08/2006
5Proton Pump InhibitorsIBA
01/2022 - 10/2016
5AlbuminsIBA
01/2022 - 06/2010
5Pharmaceutical PreparationsIBA
01/2021 - 10/2007
5Alanine (L-Alanine)FDA Link
01/2021 - 09/2011
5EndotoxinsIBA
03/2017 - 07/2007
5Acute-Phase Proteins (Acute-Phase Protein)IBA
06/2016 - 09/2006
4BilirubinIBA
01/2022 - 09/2011
4Glucagon (Glukagon)FDA Link
12/2020 - 01/2018
4Rifaximin (L 105)FDA Link
05/2018 - 06/2013
4Oxygen (Dioxygen)IBA
12/2014 - 03/2009
3CopperIBA
01/2022 - 06/2020
3CreatinineIBA
01/2022 - 09/2011
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 08/2007
3Glutamic Acid (Glutamate)FDA Link
01/2021 - 03/2009
3Alanine Transaminase (SGPT)IBA
01/2021 - 01/2020
3Biomarkers (Surrogate Marker)IBA
01/2020 - 09/2014
3Vasopressins (Vasopressin)IBA
11/2019 - 06/2013
3LipidsIBA
10/2019 - 03/2003
3BenzodiazepinesIBA
04/2018 - 11/2015
3CytokinesIBA
01/2018 - 09/2016
3NeomycinFDA LinkGeneric
01/2017 - 02/2015
3Interleukin-6 (Interleukin 6)IBA
06/2016 - 04/2011
3DisaccharidesIBA
05/2016 - 01/2016
3lactitolIBA
05/2016 - 01/2016
3Tricarboxylic AcidsIBA
04/2011 - 06/2007
2Neurotransmitter Agents (Neurotransmitter)IBA
03/2022 - 06/2011
2Spironolactone (Aldactone)FDA LinkGeneric
01/2022 - 11/2015
2Furosemide (Lasix)FDA LinkGeneric
01/2022 - 11/2015
2Protons (Proton)IBA
01/2022 - 01/2019
2C-Reactive ProteinIBA
02/2021 - 06/2010
2SteroidsIBA
01/2021 - 01/2004
2InterleukinsIBA
01/2021 - 01/2020
2Antiviral Agents (Antivirals)IBA
01/2020 - 08/2014
2Carrier Proteins (Binding Protein)IBA
01/2020 - 09/2014
2Glucagon Receptors (Glucagon Receptor)IBA
11/2019 - 10/2019
2Ligases (Synthetase)IBA
11/2019 - 07/2007
2Nonesterified Fatty Acids (NEFA)IBA
11/2019 - 04/2014
2Carbamyl Phosphate (Carbamoyl Phosphate)IBA
11/2019 - 07/2007

Therapy/Procedure

13Transjugular Intrahepatic Portasystemic Shunt
04/2015 - 01/2003
10Therapeutics
01/2022 - 08/2007
9Surgical Portasystemic Shunt (Portosystemic Shunt)
04/2015 - 01/2003
3Liver Transplantation
01/2019 - 03/2003
3Ligation
11/2008 - 09/2006
2Activities of Daily Living (ADL)
03/2022 - 01/2021
2Bariatric Surgery
01/2021 - 08/2015
2Resistance Training
01/2020 - 01/2019